Next-Generation Multi-Omics to Identify Dynamic Biomarkers for Neurodegenerative Disease
Time: 2:00 pm
day: Translational Track Day 2 PM
Details:
- How next-generation mass spectrometry technologies are enabling large-scale, multi-omics biomarker discovery – including metabolites, lipids, and proteins
- Using precision-guided approaches for targeted multi-omic measures of established Alzheimer’s and Parkinson’s biomarkers
- Leveraging ‘discovery’ mass spectrometry to elucidate novel biomarkers of neurodegeneration and CNS drug response
